Unibest
← Back to patent-cliff list

CAS 824-94-2

1-(chloromethyl)-4-methoxybenzene

Codes: EFAV-010, Lopix-016

Application context (from source-drug indications)

HIV infectionEfavirenz/Lamivudine/Tenofovir Disoproxil FumarateHIV infectionEfavirenzCreutzfeldt-Jakob diseaseEfavirenzAlzheimer's diseaseEfavirenzPancreatic cancerEfavirenzProstate cancerEfavirenzNon-Hodgkin lymphomaEfavirenzPruritusMaralixibat Chloride进行性家族性肝内胆汁淤积症Maralixibat ChlorideAlagille综合征Maralixibat Chloride胆汁淤积Maralixibat ChlorideLiver diseaseMaralixibat Chloride肝内胆汁淤积Maralixibat Chloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Efavirenz/Lamivudine/Tenofovir Disoproxil FumarateTier C — Watch / trade-
EfavirenzTier B — Position early-
Maralixibat ChlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.